Lifebit REAL uniquely combines machine learning, artificial intelligence and real world evidence, to accelerate three key areas:

Disease
Surveillance

View White Paper

Drug
Identification

View White Paper

Target
Discovery

View White Paper

DRUG IDENTIFICATION

Discover new drug & vaccine assets

Find the most promising pharmaceutical assets earlier, to strengthen your R&D portfolio.

DRUG PIPELINE ACCELERATION

Prioritise the right drug for the right disease

Monitor the disease landscape and quantify disease occurrence, so you can prioritise your R&D pipeline accordingly.

Meet the Therapeutic Leaders

that use Lifebit REAL

Meet the Therapeutic Leaders
that use Lifebit REAL

“ We are strategically partnering with Lifebit to leverage AI to monitor and interpret scientific and other sources in real-time. “

“This will accelerate the infectious diseases detection process, as the vast amounts of scientific relevant information being produced at many levels cannot be feasibly collected and analysed manually.”

Prof. Dr. Eric Haaksma,

Prof. Dr. Eric Haaksma,

Head of Animal Health Global Innovation Boehringer Ingelheim

REAL enables every scientific and commercial decision to be informed by real world data and evidence.

- Dr. Tom Sharrock, Lifebit REAL Product Manager
Get started

1

Book
a Demo

Learn how REAL provides insights for the diseases you care most about.

2

Create
Your Blueprint

Co-develop a strategy to leverage RWE for your therapeutic areas of interest.

3

Stay
Ahead

Leverage RWE to stay ahead of your competition & at the forefront of therapeutic innovation.
Book a demo